Because increased NFkB activity at least partially enhances the intrinsic radio- or chemo-resistance of thyroid cancer cells, several specific or nonspecific inhibitors of NFkB have been tested by in vitro and in vivo studies [16,17]. The gene discussed is NFKB1; the disease is thyroid gland carcinoma.